社会经济发展:医疗保健成长机会
市场调查报告书
商品编码
1351239

社会经济发展:医疗保健成长机会

Socioeconomic Development: Healthcare Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 62 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

数位化、政策倡议和本地製造推动医疗保健及相关领域的成长机会

儘管经济预测疲软,但在新兴市场强劲成长、疫情后更强有力的健康政策、主要已开发国家高龄化预测研发支出增加的支持下,全球医疗保健产业将在2023年继续成长。预计将维持乐观。快速的技术进步和数数位转型正在改善患者的治疗效果和最后一英里的医疗服务。在通膨压力、货币政策紧缩以及加强医疗保健准备的呼声中,企业和政府需要投资于技术和创新方法,并启动政策改革以改善该领域的长期绩效。

考虑到这一点,Frost & Sullivan 每年都会使用索引技术来追踪全球医疗保健市场的竞争力。成长、创新和领导力医疗保健吸引力指数(GIL-H 指数)是一个基于四大支柱的多指数指数:成长 (G)、创新 (I)、领导力 (L) 和医疗保健 (H)。具有强大的资料驱动方法的有前景的医疗保健目的地。强大的国家排名框架对于公司了解开拓的市场至关重要,这些市场可以扩大以产生更多收益并扩大业务。随着企业在世界上留下自己的印记,政府的任务是提高本国吸引外国投资、提高收入水准和创造就业机会的能力。

这种资料驱动的工具使医疗保健行业参与者能够透过技术纯熟劳工的可用性、教育支出和专利申请来了解与规模相关的指标,例如人口和经济成长,以及一个国家的创新生态系统。透过评估,您可以建立一个管道扩大候选国。它也透过物流效率和政治稳定性来分析商业环境。排名中使用了50多个指标。

2023 年 GIL-H 指数根据吸引力对名义GDP(以 10 亿美元为单位,基于 2019 年国际货币基金组织的预测)为 200 亿美元或以上的 117 个国家进行了排名。该指数透过对 G、I、L 和 H 支柱及其下面的具体指标进行加权来为每个国家/地区创建排名。选定的国家概况强调了促进因素和挑战,对资料模型进行了补充。

区域分类

  • 非洲: 19个国家
  • 美洲: 21个国家
  • 亚太地区:23 个国家
  • 中亚: 5个国家
  • 东欧:19个国家
  • 中东:13个国家
  • 西欧 17个国家

目录

战略问题

  • 为什么成长如此困难?
  • The Strategic Imperative 8(TM)
  • 医疗保健及相关产业三大策略问题的影响
  • 成长机会推动Growth Pipeline Engine(TM)

世界经济环境

  • 全球经济环境:概述
  • 成长促进因素
  • 成长阻碍因素

成长创新领导力医疗保健 (GIL-H) 框架和调查方法

  • 国家排名框架的必要性
  • Frost & Sullivan 专有的 GIL 框架和 GIL-H 索引简介
  • 按地区和 GDP 等级分類的国家覆盖范围
  • 调查方法
  • 利用 GIL-H 指数的 3 个简单步骤
  • 2023 年 GIL-H 指数使用的指标

调查结果

  • 2023 年 GIL-H 成绩
  • GIL-H 2023 结果说明
  • 中国
  • 美国
  • 印度
  • 瑞士
  • 日本

国家案例研究

  • 中国
  • 沙乌地阿拉伯王国 (KSA)
  • 墨西哥

成长机会宇宙

  • 成长机会一:数位转型
  • 成长机会2:全球文明病的增加
  • 成长机会3:新兴市场的全民健康覆盖
  • 成长机会四:新兴市场的在地化机会
  • 成长机会5:经济快速高龄化

附录

  • GIL-H指数
  • 2023 年 GIL-H 指数使用的指标
  • 国家列表,GIL-H 指数,2023 年
  • 世界结果
  • 区域结果 非洲、美洲、亚太地区
  • 区域结果 亚太地区、中亚、东欧、中东、西欧
  • 以 GDP 等级分類的世界结果
  • 图表列表
  • 免责声明
简介目录
Product Code: PF01-90

Digitalization, Policy Impetus, and Localized Manufacturing Drive Growth Opportunities in the Healthcare and Allied Sectors

Despite a subdued economic outlook, 2023 is forecast to remain upbeat for the global healthcare industry, supported by steady emerging market growth, increased post-pandemic health-centric policies, rapidly aging populations in major developed nations, and higher R&D spending. Rapid technological advancements and digital transformation are improving patient outcomes and last-mile access to healthcare. Amid the inflationary pressures, tighter monetary policy environments, and the need for increasing healthcare preparedness, corporations and governments need to invest in technologies and innovative approaches and initiate policy reforms that boost the sector's long-term performance.

Given these conditions, Frost & Sullivan leverages an indexing methodology to track the competitiveness of healthcare markets across the globe annually. The Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index) identifies go-to destinations for healthcare using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L), and Healthcare (H) pillars. A robust country ranking framework is vital for companies to gain knowledge of untapped markets into which they can expand, generate more revenue, and scale up operations. With corporates building their footprint globally, governments are tasked with showcasing their country's ability to attract foreign investment, raise income levels, and create jobs.

This data-driven tool allows healthcare industry participants to build their go-to country pipeline by evaluating size-related indicators (e.g., population and economic growth) and the country's innovation ecosystem through skilled labor availability, education expenditure, and patent applications. It also analyzes the business environment through logistics efficiency and political stability. The ranking process uses more than 50 indicators.

The 2023 GIL-H Index ranks 117 countries with nominal GDP ($ billion, based on IMF projection for 2019) at or above $20 billion based on their attractiveness. The index generates country rankings, following the assignment of weights to the G, I, L, and H pillars and the specific indicators under them. Selected country profiles highlighting drivers and challenges supplement the data model.

Regional classification:

  • Africa: 19 countries
  • Americas: 21 countries
  • Asia-Pacific: 23 countries
  • Central Asia: 5 countries
  • Eastern Europe: 19 countries
  • Middle East: 13 countries
  • Western Europe: 17 countries

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Healthcare and Allied Industries
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Global Economic Environment

  • Global Economic Environment: An Overview
  • Growth Drivers
  • Growth Restraints

Growth Innovation Leadership Healthcare (GIL-H) Framework and Methodology

  • The Need for a Country Ranking Framework
  • Frost & Sullivan's Proprietary GIL Framework and Introduction to GIL-H Index
  • Country Coverage by Region and GDP Bracket
  • Research Methodology
  • Using GIL-H Index: A Simple 3-step Process
  • Indicators Used in the GIL-H Index 2023

Results

  • GIL-H 2023 Results
  • GIL-H 2023 Results Explained
  • China
  • United States
  • India
  • Switzerland
  • Japan

Country Case Studies

  • China
  • Kingdom of Saudi Arabia (KSA)
  • Mexico

Growth Opportunity Universe

  • Growth Opportunity 1: Digital Transformation
  • Growth Opportunity 2: Global Rise of Lifestyle Diseases
  • Growth Opportunity 3: Universal Health Coverage in Emerging Markets
  • Growth Opportunity 4: Localization Opportunities in Emerging Markets
  • Growth Opportunity 5: Rapidly Aging Economies

Appendix

  • GIL-H Index
  • Indicators Used in the GIL-H Index 2023
  • Country List, GIL-H Index, 2023
  • Global Results
  • Regional Results: Africa, Americas, Asia-Pacific
  • Regional Results: Asia-Pacific, Central Asia, Eastern Europe, Middle East, Western Europe
  • Global Results by GDP Bracket
  • List of Exhibits
  • Legal Disclaimer